Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion type Assertion NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_head.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion evidence source_evidence_literature NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion SIO_000772 23321252 NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion wasDerivedFrom befree-2016 NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.
- NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_assertion wasGeneratedBy ECO_0000203 NP1044101.RAOnMd8iUENtKjLmNJY70M6x0w4Ee3Ii4lNBNqC2Xo67Q130_provenance.